Drugs · acquisition-cost intelligence
ACTINEL Diabetic
Dextromethorphan, Guaifenesin· ingredient dextromethorphanExpectorants· DEXTROMETHORPHAN 10 mg/5mL; GUAIFENESIN 100 mg/5mL; DEXTROMETHORPHAN 20 mg/10mL; GUAIFENESIN 200 mg/10mL; DEXTROMETHORPHAN HYDROBROMIDE 10 mg/5mL; GUAIFENESIN 100 mg/5mL; DEXTROMETHORPHAN HYDROBROMIDE 15 mg/7.5mL; GUAIFENESIN 150 mg/7.5mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$0.01104
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per ML — the trend nobody else shows. 8 weeks.
2025-05-212026-05-20
Same-ingredient options by acquisition cost
Other dextromethorphan products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.
| Product | NADAC / ML | vs this |
|---|---|---|
| adult cough and chest congestion | $0.01973 | +$0.00870 |
| BACTIMICINA COUGH AND COLD | $0.02085 | +$0.00980 |
| 7 Select Maximum Strength | $0.02142 | +$0.01040 |
| Adult Cough Relief | $0.02292 | +$0.01190 |
| Promethazine DM | $0.03852 | +$0.02750 |
| AMAZON Childrens Multi Symptom Cold | $0.04678 | +$0.03570 |
| 12 HR RELIEF COUGH DM | $0.06804 | +$0.05700 |
| VANACOF DM | $0.06956 | +$0.05850 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.